title: Mixed Connective Tissue Disease in a Patient With Castleman Disease and Hodgkin Lymphoma: Excellent Clinical Response to Rituximab.
authors.affiliation: Servicio de Dermatología, Hospital de Barbastro, Huesca, España. Electronic address: tamara_gracia@hotmail.com.
authors.forename: T
authors.initials: T
authors.lastname: Gracia-Cazaña
authors.affiliation: Servicio de Reumatología, Hospital Clínico Lozano Blesa, Zaragoza, España.
authors.forename: C
authors.initials: C
authors.lastname: Delgado-Beltrán
authors.affiliation: Servicio de Dermatología, Hospital Clínico Lozano Blesa, Zaragoza, España.
authors.forename: M A
authors.initials: MA
authors.lastname: Concellón
authors.affiliation: Servicio de Hematología, Hospital Clínico Lozano Blesa, Zaragoza, España.
authors.forename: M A
authors.initials: MA
authors.lastname: Fuertes
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005871:Castleman Disease / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D008947:Mixed Connective Tissue Disease / Q000188:drug therapy / Q000209:etiology*; D011928:Raynaud Disease / Q000209:etiology; D012074:Remission Induction; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D000069283:Rituximab; D008775:Methylprednisolone